Hypertrophic cardiomyopathy (HCM) is a myocardial disease characterized by left
ventricular hypertrophy not solely explained by abnormal loading conditions. Despite its rare …

Cardiomyopathies (CMPs) represent a diverse group of heart muscle diseases, grouped into
specific morphological and functional phenotypes. CMPs are associated with mutations in …

The diffusion of next-generation sequencing (NGS)-based approaches allows for the
identification of pathogenic mutations of cardiomyopathies and channelopathies in more …

Abstract “Athlete's heart” is a spectrum of morphological, functional, and regulatory changes
that occur in people who practice regular and longterm intense physical activity. The …

Multimodality imaging is a comprehensive strategy to investigate left ventricular hypertrophy
(LVH), providing morphologic, functional, and often clinical information to clinicians …

Several treatments have demonstrated safety and effectiveness in the treatment of patients
with hypertrophic cardiomyopathy; however, no drug has been shown to modify the natural …

Fabry disease (FD)(OMIM# 301500) is a rare genetic lysosomal storage disorder (LSD).
LSDs are characterized by inappropriate lipid accumulation in lysosomes due to specific …

KEY POINTS Fabry disease is a multisystemic disease that can affect several organs,
resulting in cardiac, neurologic, ocular, cutaneous, and renal manifestations. Age at onset …

Aims To evaluate the role of bisoprolol to control symptoms and left ventricular outflow tract
obstruction (LVOTO) in a consecutive cohort of adults with hypertrophic cardiomyopathy …

The Risk of Sudden Unexpected Cardiac Death in Children - Heart Failure Clinics Skip to Main
Content Advertisement Heart Failure Clinics Log in Register Log in Subscribe Claim Skip menu …